CARLSBAD, Calif., July 8, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target ...

“Others have created a crisis out of an unpolitical poster that supports the basic sentiment ‘Everyone is Welcome’ in this district,” said Jeremiah Brenot, a Renaissance High School Graduate.

CHICAGO, May 15, 2025--MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been accepted for the 28th Annual ...

TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer.

BOSTON, April 28, 2025 /PRNewswire/ -- AVEO Oncology, an LG Chem company ("AVEO"), a biopharmaceutical company committed to providing differentiated solutions to improve cancer patients lives ...

Zentalis Pharmaceuticals announces poster presentation at ASCO 2025 for azenosertib in metastatic colorectal cancer.

The poster can be accessed through the “Supporting Publications” tab on the “Our Approach” section of the Zentalis website on the day of the presentation.

Session Date: May 7-10, 2025 Presentation Start: May 7, 2025, 8:30 am CET A copy of the poster will be available on the Posters section of the MetaVia website after the presentation. About DA-1241 ...

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...